Potential of extracellular vesicles for early prediction of severity and potential risk stratification in critical inflammatory diseases.
Ontology highlight
ABSTRACT: Some acute inflammatory diseases are often exacerbated during or after hospitalization, leading to some severe manifestations like systemic inflammatory response syndrome, multiple organ failure, and high mortality. Early clinical predictors of disease severity are urgently needed to optimize patient management for better prognosis. The existing clinical scoring system and laboratory tests cannot circumvent the problems of low sensitivity and limited specificity. Extracellular vesicles (EVs) are heterogeneous nanosecretory vesicles containing various biomolecules related to immune regulation, inflammation activation, and inflammation-related complications. This review provides an overview of EVs as inflammatory mediators, inflammatory signaling pathway regulators, promoters of inflammatory
SUBMITTER: Deng Y
PROVIDER: S-EPMC10189682 | biostudies-literature | 2023 May
REPOSITORIES: biostudies-literature
ACCESS DATA